OXYGENTAPH logo

Oxygenta Pharmaceutical Ltd

OXYGENTAPH·BSE·
54.20 -1.73 (-3.09%)
Market Cap203.41 Cr
PE Ratio
Volume30,302
Day High - Low58.71 - 54.20
52W High-Low71.59 - 43.00
DocStoX Score
4.2/10
Weak
Fair Value
Sign in to see
ROE
41.16%
Strong
P/E
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day54.20
58.71
52W43.00
71.59
DocStoX take

Supported by growth (7.5), but held back by quality (1.8). Growth looks strong at 7.5, but that is offset by quality at 1.8. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Low confidence
4.2
/10
Weak
Quality
Weak
ROE 41.2%
Valuation
No data
No valuation multiples
Growth
Strong
Revenue +16.9% 5Y CAGR
Risk
Elevated
D/E 0.00
Momentum
Soft
39% of 52-week range

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹203 Cr
52W High / Low
₹72 / ₹43
Dividend Yield
0.00%
Promoter Holding
56.54%
EPS (TTM)
₹-2.79
Book Value

Key highlights

  • Strong returns on equity (41%)
  • Low leverage — D/E 0.00
  • Revenue compounding 17% a year
  • Loss-making in some of the last 5 years
  • Quality is weak (1.8/10)
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Oxygenta Pharmaceutical Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.